Introduction
Salivary glands (SGs) have an important role in providing lubrication for digestion and protection of the oral tissues. In addition to the major SGs (reviewed in Tucker (2007) ), the mammalian oral cavity also contains many minor SGs. These small glands provide ongoing protection to the oral tissues by secreting saliva continuously (Hand et al., 1999) . Furthermore, study of developing minor SGs may reveal new information about the development of related epithelial structures such as the hair follicles, teeth or other glands. Despite their importance to oral health and potential interest to developmental biologists, the mechanisms of minor salivary gland (SG) development are largely unexplored.
The minor SGs are located in the submucosa of the tongue, cheeks and palate and secrete mostly mucus saliva. These glands are simpler in structure than the major SGs, lacking a complex branched ductal system and existing continuously within the surrounding connective tissue, rather than within a mesenchyme capsule (Hand et al., 1999) . The development of the murine submandibular gland (SMG), the largest major SG, has been clearly characterized and develops from a thickening of the oral epithelium at E11.5, subsequently undergoing bud formation, branching morphogenesis and terminal differentiation. This process involves an array of signalling pathways including Sonic Hedgehog (Shh), Fibroblast Growth Factor (Fgf) and Ectodysplasin A (Eda) (Jaskoll and Melnick, 1999; Hoffman et al., 2002; Jaskoll et al., 2004a,b; Wells et al., 2010) . By contrast, information on the genes involved in minor SG development is lacking, although it has been shown that the homeobox transcription factor Nkx3.1 is expressed during mouse minor SG development and plays a role in duct morphogenesis (Schneider et al., 2000) .
The Eda signalling pathway is required for ectodermal organ development. Mutations in Eda pathway genes cause hypohidrotic ectodermal dysplasia (HED), characterized by defective development of the hair, teeth and exocrine glands (Clarke et al., 1987) . EDA encodes the tumour necrosis factor-like ligand EDA A1 (Srivastava et al., 1997) . EDA A1 signals through its receptor EDAR and an intracellular adaptor protein EDARADD (Headon et al., 2001) , and instigates downstream activation of NFκB (Kumar et al., 2001) . Recessive mutations in EDA are responsible for X-linked HED, the most common form of HED (Kere et al., 1996) , while dominant and recessive mutations in EDAR and EDARADD have been found in families carrying autosomal HED (Monreal et al., 1999; Headon et al., 2001) . The spontaneous mouse mutants Eda Ta/Ta , Edar dlJ/dlJ and Edaradd Cr/Cr (Srivastava et al., 1997; Monreal et al., 1999; Headon et al., 2001 ) exhibit a similar phenotype to human HED in that the development of the hair, teeth and exocrine glands is impaired (Falconer et al., 1951; Grüneberg, 1965; Claxton, 1967; Grüneberg, 1971; Blecher et al., 1983) . Analysis of Eda pathway mutant mice has revealed that Eda signalling plays a role in SMG branching morphogenesis (Jaskoll et al., 2003; Wells et al., 2010) , but the role of Eda signalling in minor SG development has not been examined thoroughly. The classical study of gland development in Eda Ta/Ta states that lingual and palatal minor SGs are absent in Eda Ta/Ta embryos (Grüneberg, 1971) , although it is unclear whether this represents developmental delay or a failure of initiation. As well as the minor SG defect, Grüneberg (1971) Contents lists available at ScienceDirect Developmental Biology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / d e v e l o p m e n t a l b i o l o g y dysplastic circumvallate papilla (CVP), an epithelial structure at the back of the tongue associated with taste receptors and minor SGs. Rescue of Eda pathway mutant phenotypes has been achieved using a number of methods. Injection of a recombinant form of EDA A1 given to pregnant Eda Ta/Ta mothers leads to rescue of the organs affected in the developing embryos (Gaide and Schneider, 2003) , although the effect on the SGs was not documented. In vitro, addition of recombinant EDA A1 to Eda Ta/Ta skin or SMG cultures rescues primary hair placode and major SG branching respectively (Mustonen et al., 2004; Wells et al., 2010) . Recent qPCR profiling has revealed downregulation of Shh and Fgf8 in Eda Ta/Ta major SGs (Melnick et al., 2009 ). The branching defect in Eda pathway mutant SMG explants can be rescued with Shh, but not Fgf8 (Wells et al., 2010) . Shh is also a target of Eda signalling in skin, but treatment of Eda Ta/Ta skin with exogenous Shh does not rescue primary hair placode formation (Pummila et al., 2007) . In this paper we have sought to provide the first characterization of minor SG development in wild type (WT) and Eda pathway mutant mice, and to test the ability of exogenous EDA A1, Fgf8 and Shh to rescue Eda pathway mutant minor SGs using a novel minor SG culture system.
Results

Eda pathway mutant embryos lack developing minor SGs
We began by analysing WT and Eda pathway mutant minor SG histology during mouse embryogenesis. In the WT, the glands present on the lateral part of the tongue are the first to initiate. These glands are first visible at E15.5 as downgrowths of the posterior lateral tongue epithelium. A number of lingual glands located closer to the midline initiate slightly later, and are visible at E15.5 as small buds (Fig. 1A, D In the E17.5 WT, some of the developing lingual glands have formed distinct ductal and acinar structures, with hollowed out ducts forming well defined lumina. There is evidence of mucus production at E17.5 and E18.5, as indicated by Alcian blue staining within the ducts and end buds. In addition, a number of glands are now visible on the palate (Fig. 1F,H,K) . In Eda pathway mutant embryos of the same stage, histological signs of developing minor SGs are absent (Fig. 1G,  I ). The structures examined in the WT were confirmed to be developing minor SGs by in situ hybridisation of Nkx3.1 (Schneider et al., 2000) (Fig. 1J) .
The sequential appearance of minor SGs in different locations on the tongue and palate was consistent in all the embryos we examined, and we also noticed that glands simultaneously arose in identical locations on the left and right sides of the embryo (Fig. 1A) . This indicates that the stage at which minor SGs develop, and their positioning within the oral cavity, is highly regulated.
Mucous minor SGs are absent in Eda pathway mutant adults
To confirm whether the embryonic Eda pathway mutant minor SG defects persist into adulthood, we compared sections of adult Eda pathway mutant and WT oral cavities (Fig. 2) . In the WT, a large number of mucous glands are present on the palate and tongue. A number of serous glands are also observed in association with the CVP (Von Ebner's glands) anterior to the lingual mucous glands ( Fig. 2A) (Fig. 3A and B.
Edar dlJ/dlJ and Edaradd Cr/Cr not shown), appearing as a downward fissure rather than a raised dome. During WT early tongue development, Shh is expressed in the developing epithelial dome of the CVP where it is thought to regulate proliferation and epithelial invagination leading to the structure's characteristic morphology (Lee et al., 2006; Kim et al., 2009) (Fig. 3C) . In Eda Ta/Ta , Shh expression was restricted to one side of the developing CVP and was absent from the opposite wall of the dome where no epithelial trench had formed (Fig. 3D ). Therefore, in the absence of Eda, CVP Shh expression appears disrupted, resulting in loss of the trench on one side.
Eda, Shh and Fgf pathway genes are expressed from the earliest stages of minor SG development
To shed light on the mechanisms regulating the induction and early development of the minor SGs, we studied the expression of a selection of genes during early minor SG development. Because minor SGs fail to initiate in Eda pathway mutant mice, we first chose to examine Eda pathway activity. In addition, we examined the expression of Shh and Fgf pathway genes, because these pathways are possible targets of Eda signalling (Pummila et al., 2007; Melnick et al., 2009) . To study Eda pathway activity, we examined the expression of Edaradd, since the expression of this gene likely reflects the location where the pathway is acting. At E15.5, Edaradd was expressed in the budding minor SGs and throughout the oral epithelium ( Fig. 3E and F) . At the same stage, Shh mRNA was weakly detected in the budding glands but not throughout the oral epithelium (except in the developing rugae) ( Fig. 3G and H) . Ptc1, the Shh signalling receptor and target, was expressed in the budding glands, particularly at the distal portion of the bud (Fig. 3I ). To examine Fgf signalling activity, we studied the expression of Erm, an Ets-family transcription factor target of Fgf signalling (Wasylyk et al., 1998) . Erm was detected strongly in the budding glands at an early stage of development. Erm expression was confined to the developing glands, and was not detected in the oral epithelium (Fig. 3J ).
Minor SGs fail to develop in Eda
Ta/Ta tongue explants
We developed a novel minor SG culture system allowing us to follow the development of lingual minor SGs in tongue explants. After development of E13.5 WT whole tongues for 48 hours in vitro, developing minor SG buds were visible at the posterior lateral area of the tongue (Fig. 4A ). Minor SG buds were absent in Eda Ta/Ta tongues at this stage (Fig. 4C ). After 72 hours in culture, more buds were visible on the lateral WT tongue, and further buds appeared closer to the midline ( Fig. 4B ), in agreement with our histological data. Developing lingual glands remained absent in Eda Ta/Ta tongues at this stage ( Fig. 4D ).
To quantify these observations, the tongue explants were sectioned and subjected to histology staining and in situ hybridisation of an Nkx3.1 probe. Developing minor SGs, as defined by Nkx3.1 expressing epithelial thickenings, were counted over all sections from each explant, and the number of developing glands in WT, Eda Ta/+ and Eda Ta/Ta explants compared. While no Nkx3.1 expressing regions were present in Eda Ta/Ta tongues (Fig. 4F, H, I ), a mean of~6 Nkx3.1 positive developing lingual glands were present in WT tongues (Fig. 4E, G, I ). Nkx3.1 positive lingual glands were present in Eda Ta/+ , but appeared reduced in number in comparison with WTs (Fig. 4I) . (Fig. 5B, D, E) . A trend towards increased minor gland number was also observed in WT and Eda Ta/+ tongues treated with EDA A1 in comparison with untreated WT tongues (Fig. 5E ).
Exogenous Shh and Fgf8 do not fully rescue minor gland induction in Edar dlJ/dlJ
We tested whether application of exogenous Shh or Fgf8, potential targets of Eda signalling, would result in rescue of the minor SGs in Eda pathway mutant tongues. For these experiments, we moved to Edar dlJ/dlJ tongues. These mice lack functional Edar, and we considered them the best system for a downstream rescue since the possibility of activating signalling via Edar is abolished. E13.5 Edar dlJ/dlJ tongues were cultured with either 500 ng/mL Fgf8b or 2.5 μg/mL Shh-N peptide, and control tongues were cultured in the absence of recombinant protein. These proteins were also tested simultaneously on SMG explants to confirm that they were functional (Wells et al., 2010) . After 4 days in culture, tongue explants were sectioned and subjected to histology staining and in situ hybridisation of an Nkx3.1 probe. No Nkx3.1 expression was detected in control Edar dlJ/dlJ explants. In 3/19 Fgf8b-treated tongues, weak Nkx3.1 expression was evident in 1 or 2 gland-like structures, indicating possible rescue of minor SGs in a limited number of explants ( Fig. 6A-D) . No Nkx3.1 expression was detected in Shh-treated Edar dlJ/dlJ explants, although
Nkx3.1-negative gland like structures were noted. In location and morphology, these structures were similar to minor SGs, suggesting that Shh causes the induction of a small number of glands which then do not develop further (Fig. 6E-H, J) . Expression of Nkx3.1 was detected in developing glands in Edar dlJ/+ tongues as expected (Fig. 6I ).
Discussion
Minor SGs develop by epithelial downgrowth and are highly regulated
Our data represents, to our knowledge, the first thorough description of minor SG development in the mouse. We show that the minor SGs develop by epithelial thickening and budding, and subsequent downgrowth and differentiation. However, unlike the SMGs, the minor SGs lack a mesenchyme capsule (Hand et al., 1999) . This raises the question of where the signals instructing the positioning and development of the glands reside. Recombination experiments have shown that major SG branching is driven by the surrounding mesenchyme (Grobstein, 1953) , but it has been speculated that the initiation signals may come from the oral epithelium as in the developing tooth (Tucker, 2007) . Our data showing that the minor glands are able to initiate development without signals from a mesenchyme capsule certainly suggests that the major SGs may be able to do the same, only requiring mesenchymal signals to instruct later branching morphogenesis. It is tempting to speculate that the minor SGs do not branch extensively because they do not have access to such stimulatory signals as those secreted by the major SG mesenchyme.
To date the only known marker of developing minor SGs was Nkx3.1 (Schneider et al., 2000) . Here we show that Edaradd, Shh, Ptc1 and Erm also mark the minor SGs from the earliest stages of their development. Shh is a known mitogen (Ingham and McMahon, 2001) and it seems likely that its function in the developing minor SG is to promote proliferation and epithelial downgrowth, as in the developing hair follicle (Millar, 2002) . In addition, our data showing expression of both Ptc1 and Shh in the epithelium, rather than in separate tissue compartments, indicates that Shh signalling regulates minor SG development in an autocrine manner. Fgf signalling is required for major SG development (reviewed in Tucker (2007)), and our finding of strong Erm expression in the developing minor SGs is in agreement with this. (Lexner et al., 2007) . No information is yet available on the signalling mechanisms involved in initiating development of major or minor SGs; our work indicates an involvement for Eda signalling. The literature also lacks information on genes involved in determining the type of SG that will develop. The specific requirement for Eda in mucous minor SG initiation contrasts with the case of the SMGs (Melnick et al., 2009 ) and serous minor SGs, which do not require Eda signalling for initiation, and evokes the different requirements for Eda in the distinct types of hair follicles. In Eda Ta/Ta , secondary and tertiary hair follicles initiate normally, but primary hair follicles fail to initiate (Laurikkala et al., 2002) . 
Eda pathway mutant minor SGs can be rescued with recombinant EDA A1 in vitro
Using our minor SG culture system, we show that supplementation of E13.5 Eda Ta/Ta tongues with EDA A1 results in rescue of gland development. This agrees with data showing that exogenous EDA A1 rescues primary hair follicle development in Eda Ta/Ta skin explants (Laurikkala et al., 2002) . EDA A1 injection has been shown to rescue most aspects of the Eda Ta/Ta phenotype (Gaide and Schneider, 2003) and as a result recombinant EDA A1 is promising a cure for sufferers of HED. HED patients demonstrate reduced whole saliva flow (Nordgarden et al., 2001) leading to xerostomia (dry mouth), a reduced quality of life and further damage to an already compromised dentition. However, the ability of this protein to rescue minor SG development in Eda Ta/Ta had not been studied.
Our findings are encouraging for future attempts to correct SG defects in HED patients. Although our histological studies showed an absence of minor SGs in Eda pathway mutant embryos, the fact that these glands are rescued with EDA A1, and that they develop in the expected position, implies that a group of cells able to respond to the signal are in fact present in Eda pathway mutants.
Exogenous Shh and Fgf8 do not fully rescue minor gland induction in Edar dlJ/dlJ
QPCR data has indicated that Shh is a potential target of Eda signalling in the SMGs (Melnick et al., 2009) , and treatment of embryonic Eda Ta/Ta skin cultures with recombinant EDA A1 results in upregulation of Shh (Pummila et al., 2007) . A number of Nkx3.1 expression domains in the developing embryo, such as the prostate gland, are dependent on Shh (Schneider et al., 2000) . We were unable to demonstrate rescue of Nkx3.1 expression in Edar dlJ/dlJ tongue explants by Shh supplementation, although we did observe the presence of gland-like tissue. Shh overexpression is associated with tumour formation in the skin (Oro et al., 1997) , and it is possible that the tissue we observe is the result of overproliferation. Our finding that Shh is not sufficient to completely rescue minor SG development in the absence of Eda signalling agrees with data showing that exogenous Shh is unable to rescue primary hair placode induction in Eda Ta/Ta skin cultures (Pummila et al., 2007) .
Fgf8 is another potential target of Eda signalling in the SMGs (Melnick et al., 2009) . Other studies have shown growth factor mediated rescue of aspects of the Eda Ta/Ta phenotype. EGF injection administered to Eda Ta/Ta pups rescues sweat gland development (Blecher et al., 1990) . In embryonic Eda Ta/Ta tooth explants, cusp morphogenesis is partially rescued by exogenous Fgf10 (Pispa et al., 1999) , although it is unclear whether this is through a mechanism independent of Eda signalling, such as an increase in epithelial proliferation. In our study, 3 out of 19 cultures showed induction of Nkx3.1-positive minor SG structures in response to Fgf8 supplementation, indicating that Fgf8 is not sufficient to rescue reliably. This may 
Genotyping
DNA was extracted by digestion of tail snip tissue in 0.5 mg/mL proteinase K at 55°C overnight, followed by phenol chloroform purification and ethanol precipitation. Genotype of E13.5 WT, Eda Ta/+ and Eda Ta/Ta embryos was identified by PCR analysis using primer sets specific for Eda (covering the exon 1 region deleted in Eda Ta/Ta and therefore failing to generate a product from Eda mutant DNA), Y chromosome and Actin (for positive control). Primer sequences were: EDA: 5′-AGGA-CAGTAGTCGCCTGT-3′ (forward), 5′-GCCGCCGCCCTTCCTAGG-3′ (reverse). Y chromosome: 5′-CTGGAGCTCTACAGTGATGA-3′ (forward), 5′-CAGTTACCAATCAACACATCAC-3′ (reverse). Actin: 5′-GCTTCTGA-GATGTCTCTCTCT-3′ (forward), 5′-ACACAGGCTTTTGTAGGTTGC-3′ (reverse). These primers generated 509 bp (Eda), 343 bp (Y chromosome) and 159 bp (Actin) fragments. The Edar mutant animals used in this study were of the downless Jackson strain which possess a G to A point mutation within the Edar death domain . Genotype of E13.5 Edar dlJ/dlJ and Edar dlJ/+ embryos was determined by PCR analysis using Edar specific primers, the forward primer containing a one nucleotide mismatch from the template DNA. The mismatch enabled the generation of a TaqI restriction site unique to the WT sequence. Primer sequences were 5′-TGAAAACATGGCGCCACCTTGTC-3′ (forward, mismatch underlined), 5′-TCACTCACAGCTGTCGGTCGTG-3′ (reverse). These primers generated a 309 bp product. Overnight digestion of Edar dlJ/dlJ product with TaqI (Sigma) at 65°C resulted in 142 bp and 167 bp fragments (due to a natural TaqI site within the PCR product), whereas restriction of Edar dlJ/+ product resulted in fragments of 167 bp, 142 bp, 120 bp and 22 bp. Fragments were visualised on a 3% agarose gel. The mismatch primer was designed using dCAPS Finder 2.0 online software. PCR cycling conditions were as follows: 94°C 2 min 30 s, 94°C 30 s, 54°C 30 s, 72°C 1 min for 36 cycles.
Tissue processing and sectioning
Tissues were fixed in 4% paraformaldehyde (PFA) at 4°C overnight and washed in PBS before dehydration in a methanol and isopropanol series, and clearing in 1,2,3,4-tetrahydronaphthalene. Adult heads were additionally subjected to decalcification in 1% PFA and 25% 0.5 M EDTA in PBS for 2 weeks prior to dehydration. Cleared samples were incubated in paraffin wax at 65°C before embedding in moulds. Sections were cut to a thickness of 8 μm, mounted on glass slides (Superfrost Plus™, VWR International) and dried on a 42°C hotblock overnight.
In situ hybridisation
Radioactive in situ hybridisation of 35 S-UTP-labelled Edaradd probe was performed as described in Tucker et al. (1999) . Edaradd was linearized with Spe1 and transcribed with T3. Sections were counterstained with methyl green and photographed under darkfield. In situ hybridisation of dioxygenin-labelled Shh, Ptc1, Erm and Nkx3.1 probes was performed according to modified Wilkinson procedures (Wilkinson, 1995) and sections were counterstained with eosin. Shh was linearized with EcoRI and transcribed with T7. Nkx3.1 was linearized with EcoRV and transcribed with T7. Ptc1 was linearized with BamHI and transcribed with T3. Erm was linearized with HindIII and transcribed with T7.
Histology staining
Sections were cleared with Histoclear™, rehydrated through an ethanol series and washed in dH 2 O. Sections were stained with haemotoxylin and eosin (H&E) and differentiated in acid alcohol, or alternatively were stained with Sirius red in picric acid, Alcian blue and haemotoxylin (trichrome) where appropriate. After staining, sections were washed in dH 2 O, dehydrated through an ethanol series, cleared in xylene and coverslipped with DPX mounting medium.
Organ culture
Tongues were dissected whole in complete culture medium and care was taken to remove all SMG tissue. Explants were mounted on membranes (BD Falcon cell culture inserts) and floated over culture medium in glass bottom dishes (MatTek Corporation). Medium for experimental explants was supplemented with recombinant Fc-EDA A1 (Gaide and Schneider, 2003) Fgf8b, or Shh-N peptide (R&D Systems) . Explants were cultured in a 37°C, 5% CO 2 incubator, photographed and the medium changed daily.
Analysis
Unpaired t-tests were performed for statistical comparison of groups of data and p values are shown in the figures. Data were analysed and converted to charts using Microsoft Office Excel 2007. The level of statistical significance was taken as p b 0.05.
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